Results from Phase 2 Studies of Oral Ozanimod in Crohn』s Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017
In the STEPSTONE open-label study, ozanimod demonstrated meaningful clinical and endoscopic improvements in patients with moderately to severely active Crohn』s disease at week 12 In the TOUCHS......
